Ppis + Clarithromycin + Amoxicillin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: (PPI): 30 mg + Amoxicillin: 500 mg + Clarithromycin: 500 mg
Reference Brands: Prevpac(US)
Category: Gastrointestinal Drugs
PPIs bind to stomach H+/K+ ATPase enzymes, reducing acid secretion, creating a less hospitable environment for H. pylori. Clarithromycin and Amoxicillin target and eliminate the bacteria. The combination effectively eradicates H. pylori, relieves ulcers, and prevents gastric cancer. Benefits include symptom relief, mucosal healing, and reduced recurrence.
Product Description:
PPIs combined with clarithromycin and amoxicillin tablets are approved in the US by the FDA and in the EU via EMA for Helicobacter pylori eradication. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports swift approval, safe use, and worldwide availability, helping healthcare providers effectively treat H. pylori infections and prevent gastric complications globally.
Ppis + Clarithromycin + Amoxicillin Tablets — third party manufacturing & bulk supply
Ppis + Clarithromycin + Amoxicillin Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ppis + Clarithromycin + Amoxicillin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ppis + Clarithromycin + Amoxicillin Tabl... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
PPIs, clarithromycin, and amoxicillin are used in combination therapy for the eradication of Helicobacter pylori infection associated with peptic ulcer disease. This triple therapy helps reduce stomach acid, eliminate the bacteria, and promote healing of gastric and duodenal ulcers.
This therapy contains three components: a proton pump inhibitor (such as omeprazole, lansoprazole, or esomeprazole), clarithromycin, and amoxicillin trihydrate. The proton pump inhibitor reduces stomach acid production, while clarithromycin and amoxicillin act as antibiotics to kill Helicobacter pylori bacteria.
Common trade names for this triple therapy include Helidac, Omeclamox-Pak, and other H. pylori eradication therapy packs marketed by different pharmaceutical companies.
These combination therapy packs are produced by several pharmaceutical companies worldwide. For example, Omeclamox-Pak is marketed by Cumberland Pharmaceuticals, while other manufacturers also produce similar H. pylori treatment kits.
The generic components include a proton pump inhibitor (such as omeprazole, lansoprazole, or esomeprazole), clarithromycin, and amoxicillin trihydrate.
Brand names include Omeclamox-Pak, Helidac therapy pack, and other H. pylori eradication therapy kits marketed under different brand names.
These combination therapy packs are manufactured by multiple pharmaceutical companies in various regions, including the United States, Europe, India, and other global pharmaceutical manufacturing markets.
Related Products
Bismuth Subsalicylate
Strength:
262 mg, 525 mg
Form: Oral suspension / Tablet
Reference Brands: Pepto-Bismol (USA/LATAM),
View Details
Quick Response Guaranteed | Verified Suppliers
